LLY
Eli Lilly and Company · Healthcare · Drug Manufacturers - General
Input di momentum (manager comparabili):
ampiezza dei detentori -3.4% ·
flusso azionario -1.6% ·
nuove posizioni nette -3.6%
— formula
Distribuzione diffusa — azioni in calo e minor numero di detentori
Tutte le cifre di proprietà: solo gestori 13F monitorati, posizioni in azioni ordinarie, periodo di riferimento Q2 2025
| Trimestre | Detentori | Δ | Quote | Valore dichiarato | Nuovo | Uscite |
|---|---|---|---|---|---|---|
| Q2 2026 | 193 | +4 | 671.92M | $804.91B | +6 | −1 |
| Q1 2026 | 191 | -3 | 666.59M | $613.20B | +1 | −5 |
| Q4 2025 | 193 | +2 | 707.04M | $758.81B | +3 | — |
| Q3 2025 | 27 | -3 | 329.88M | $251.63B | +2 | −6 |
| Q2 2025 | 28 | -1 | 307.45M | $239.60B | +2 | −3 |
| Q1 2025 | 26 | 0 | 140.32M | $115.83B | +1 | −1 |
| Q4 2024 | 26 | +1 | 145.00M | $111.91B | +3 | −2 |
| Q3 2024 | 24 | +2 | 109.89M | $97.29B | +2 | — |
| Q2 2024 | 22 | — | 112.43M | $101.75B | — | — |
| # | Gestore | Quote | Δ azioni | Valore | Il loro peso | Detenuto | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passivo) | 80.41M | — | $62.68B | 1.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passivo) | 80.41M | — | $62.68B | 1.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passivo) | 80.41M | — | $62.68B | 1.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passivo) | 80.41M | — | $62.68B | 1.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passivo) | 80.41M | — | $62.68B | 1.0% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passivo) | 80.41M | — | $62.68B | 1.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 28 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 29 | BlackRock ✦ (passivo) | 65.96M | — | $51.42B | 1.0% | n/c | 1 | SEC ↗ |
| 30 | State Street Global Advisors ✦ (passivo) | 34.51M | +0.2% | $26.90B | 1.0% | ▲ Add | 3 | SEC ↗ |
| 31 | Fidelity (FMR) ✦ | 25.63M | — | $19.98B | 1.1% | n/c | 1 | SEC ↗ |
| 32 | Fidelity (FMR) ✦ | 25.63M | — | $19.98B | 1.1% | n/c | 1 | SEC ↗ |
| 33 | Fidelity (FMR) ✦ | 25.63M | — | $19.98B | 1.1% | n/c | 1 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 25.63M | — | $19.98B | 1.1% | n/c | 1 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 25.63M | — | $19.98B | 1.1% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 25.63M | — | $19.98B | 1.1% | n/c | 1 | SEC ↗ |
| 37 | Geode Capital Management ✦ (passivo) | 18.13M | -2.1% | $14.07B | 1.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Geode Capital Management ✦ (passivo) | 18.13M | -2.1% | $14.07B | 1.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Capital World Investors ✦ | 17.63M | -4.1% | $13.75B | 2.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | T. Rowe Price ✦ | 16.85M | -12.0% | $13.13B | 1.5% | ▼ Trim | 5 | SEC ↗ |
| 41 | T. Rowe Price ✦ | 16.85M | -12.0% | $13.13B | 1.5% | ▼ Trim | 5 | SEC ↗ |
| 42 | Wellington Management ✦ | 13.99M | +10.1% | $10.91B | 2.0% | ▲ Add | 5 | SEC ↗ |
| 43 | Wellington Management ✦ | 13.99M | +10.1% | $10.91B | 2.0% | ▲ Add | 5 | SEC ↗ |
| 44 | Wellington Management ✦ | 13.99M | +10.1% | $10.91B | 2.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Wellington Management ✦ | 13.99M | +10.1% | $10.91B | 2.0% | ▲ Add | 5 | SEC ↗ |
| 46 | Wellington Management ✦ | 13.99M | +10.1% | $10.91B | 2.0% | ▲ Add | 5 | SEC ↗ |
| 47 | Wellington Management ✦ | 13.99M | +10.1% | $10.91B | 2.0% | ▲ Add | 5 | SEC ↗ |
| 48 | Wellington Management ✦ | 13.99M | +10.1% | $10.91B | 2.0% | ▲ Add | 5 | SEC ↗ |
| 49 | Wellington Management ✦ | 13.99M | +10.1% | $10.91B | 2.0% | ▲ Add | 5 | SEC ↗ |
| 50 | Wellington Management ✦ | 13.99M | +10.1% | $10.91B | 2.0% | ▲ Add | 5 | SEC ↗ |
| 51 | PRIMECAP Management ✦ | 12.15M | -17.8% | $9.48B | 7.5% | ▼ Trim | 5 | SEC ↗ |
| 52 | Norges Bank ✦ (passivo) | 11.32M | +3.0% | $8.83B | 1.1% | ▲ Add | 5 | SEC ↗ |
| 53 | Fisher Asset Management ✦ | 4.30M | -20.9% | $3.35B | 1.3% | ▼ Trim | 5 | SEC ↗ |
| 54 | Tiger Global Management ✦ | 1.51M | +13.2% | $1.18B | 3.5% | ▲ Add | 5 | SEC ↗ |
| 55 | Marshall Wace ✦ | 931.73K | +122.1% | $726.31M | 0.9% | ▲ Add | 5 | SEC ↗ |
| 56 | Marshall Wace ✦ | 931.73K | +122.1% | $726.31M | 0.9% | ▲ Add | 5 | SEC ↗ |
| 57 | Marshall Wace ✦ | 931.73K | +122.1% | $726.31M | 0.9% | ▲ Add | 5 | SEC ↗ |
| 58 | Citadel Advisors ✦ | 853.25K | +78.6% | $665.14M | 0.6% | ▲ Add | 5 | SEC ↗ |
| 59 | Citadel Advisors ✦ | 853.25K | +78.6% | $665.14M | 0.6% | ▲ Add | 5 | SEC ↗ |
| 60 | Adage Capital Partners ✦ | 841.81K | +13.5% | $656.22M | 1.1% | ▲ Add | 5 | SEC ↗ |
| 61 | Millennium Management ✦ | 570.89K | -16.2% | $445.03M | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 62 | D. E. Shaw & Co. ✦ | 528.13K | -7.9% | $411.69M | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 63 | D. E. Shaw & Co. ✦ | 528.13K | -7.9% | $411.69M | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 64 | Viking Global Investors ✦ | 416.92K | Nuovo | $325.00M | 0.9% | New | 1 | SEC ↗ |
| 65 | AQR Capital Management ✦ | 346.98K | -38.9% | $269.65M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 66 | AQR Capital Management ✦ | 346.98K | -38.9% | $269.65M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 67 | AQR Capital Management ✦ | 346.98K | -38.9% | $269.65M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 68 | AQR Capital Management ✦ | 346.98K | -38.9% | $269.65M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 69 | AQR Capital Management ✦ | 346.98K | -38.9% | $269.65M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 70 | AQR Capital Management ✦ | 346.98K | -38.9% | $269.65M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 71 | Point72 Asset Management ✦ | 188.51K | +244.2% | $146.95M | 0.4% | ▲ Add | 2 | SEC ↗ |
| 72 | Coatue Management ✦ | 117.42K | -36.1% | $91.53M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 73 | Coatue Management ✦ | 117.42K | -36.1% | $91.53M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 74 | Duquesne Family Office ✦ | 100.67K | +6.2% | $78.48M | 2.0% | ▲ Add | 3 | SEC ↗ |
| 75 | Two Sigma Investments ✦ | 73.75K | +368.8% | $57.49M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 76 | Dodge & Cox ✦ | 44.96K | -0.3% | $35.05M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 77 | GAMCO Investors ✦ | 27.40K | -8.9% | $21.36M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 78 | Gotham Asset Management ✦ | 7.19K | -4.8% | $5.60M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 79 | Harris Associates (Oakmark) ✦ | 414 | Nuovo | $322,725 | 0.0% | New | 1 | SEC ↗ |
| 80 | Renaissance Technologies ✦ | 261 | -99.7% | $204,662 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Il loro peso" = la quota della posizione sul valore azionario 13F dichiarato da quel gestore — la misura di convinzione. ✦ = gestore selezionato.
Nuovi acquirenti
| Viking Global Investors | $325.00M | 0.9% |
| Harris Associates (Oakmark) | $322,725 | 0.0% |
Uscito
| Lone Pine Capital | $455.76M | era 4.0% |
| Arrowstreet Capital | $34.20M | era 0.0% |
| Bridgewater Associates | $2.27M | era 0.0% |
Contesto di mercato completo: su TUTTI i filer 13F (dati strutturati SEC, Q1 2026): 4,323 detentori, 762.84M azioni, $674.93B dichiarato. Questo è un periodo diverso e più vecchio rispetto ai dati dell'universo monitorato riportati sopra e i due non vengono mai combinati.
Cosa detengono più spesso gli altri holder monitorati di questo titolo — conteggi di proprietà condivisa, non relazioni fondamentali.
Acquisti sul mercato aperto (P)
Nessun acquisto insider sul mercato aperto nella nostra finestra di copertura.
Vendite sul mercato aperto (S)
Officer · 6.50K az. · $7.64M
Officer · 2.00K az. · $2.37M
Officer · 5.00K az. · $5.95M
Assegnazioni, esercizi e ritenute fiscali non vengono mai conteggiati come acquisti o vendite in questa sede. Metodologia
The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to help identify…
ForbesThe Food and Drug Administration cleared a blood test for identifying Alzheimer's disease symptoms, which was developed…
WSJThe U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help identify signs of…
ReutersThe once-daily pill was approved for patients with a body mass index of at least 30, or between 27 and 30 in the event…
WSJEli Lilly said on Monday it has launched its oral pill, Foundayo, in the UK for weight management and type 2…
Reuters